Halozyme Therapeutics
HALO
#1855
Rank
ยฃ8.13 B
Marketcap
ยฃ71.33
Share price
0.48%
Change (1 day)
32.62%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2026 (TTM): ยฃ2.66

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is ยฃ2.69. In 2025 the company made an earnings per share (EPS) of ยฃ1.99 a decrease over its 2024 EPS that were of ยฃ2.67.

EPS history for Halozyme Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ2.6633.35%
2025ยฃ1.99-25.43%
2024ยฃ2.67
2022ยฃ1.13-48.07%
2021ยฃ2.17196.87%
2020ยฃ0.73-292%
2019-ยฃ0.38-9.09%
2018-ยฃ0.42-237.5%
2017ยฃ0.31-149.38%
2016-ยฃ0.62211.54%
2015-ยฃ0.20-52.73%
2014-ยฃ0.42-24.66%
2013-ยฃ0.5648.98%
2012-ยฃ0.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.10 89.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ0.54-79.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.57 777.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.51-43.73%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-ยฃ1.08-140.06%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-ยฃ0.09918-103.69%๐Ÿ‡บ๐Ÿ‡ธ USA